The rising popularity in GLP-1 agonists for diabetes has sparked a question about application forms : transdermal systems versus capsules. Traditionally , GLP-1 therapies were only available in tablet https://royglxu832411.pointblog.net/glp-1-skin-applications-vs-tablets-what-suitable-for-the-patient-92521947